Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer's Disease Mice

Yassin Watson1, Brenae Nelson1, Jamie Hernandez Kluesner1

  • 1Laboratory for Pathology Dynamics, Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, USA.

Abstract

Insights

Apolipoprotein E3 (APOE3) genotype, advanced age, and male gender are key predictors of better cognitive function in mice. This contrasts with APOE4 and APOE knockout, which show impaired cognition.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Apolipoprotein E (APOE) genotypes are linked to Alzheimer's disease (AD) risk and amyloid-β deposition.
  • Cognitive assessments in APOE transgenic AD mouse models have yielded inconsistent results.

Purpose of the Study:

  • To analyze aggregate trends in APOE mouse models regarding age, genotype, gender, treatments, and cognitive performance.
  • To identify key factors influencing cognitive outcomes in APOE transgenic mice.

Main Methods:

  • Meta-analysis of 31 publications involving 3,045 APOE mouse models.
  • Statistical comparison of Morris water maze (MWM) performance across genotypes (WT, KI2, KI3, KI4, KO) and conditions (treated, untreated).
  • Machine learning (random forest) to predict MWM escape latency using 12 features.

Main Results:

  • APOE3 knock-in (KI3) mice showed significantly better MWM performance; APOE4 (KI4) and knockout (KO) mice performed significantly worse than wild-type (WT).
  • Positive modulatory treatments improved cognition in WT, KI4, and KO mice. Negative treatments unexpectedly improved KI4 performance.
  • Random forest model identified APOE3 genotype, age, and male gender as most important for superior MWM performance.

Conclusions:

  • APOE3 genotype, advanced age, and male gender are crucial for predicting enhanced cognitive performance in mice.
  • These factors significantly influence cognitive outcomes in APOE mouse models of Alzheimer's disease.